<DOC>
	<DOCNO>NCT02013388</DOCNO>
	<brief_summary>A study healthy subject assess safety , tolerability , pharmacokinetics N91115 .</brief_summary>
	<brief_title>MAD Study Evaluating Safety , Tolerability , Pharmacokinetic Effects N91115 Healthy Subjects</brief_title>
	<detailed_description>This Phase 1 study healthy subject conduct assess safety , tolerability , pharmacokinetics N91115 . Also , comparison fast versus fed high fat meal compare PK .</detailed_description>
	<criteria>Subject voluntarily agree participate study sign Institutional Review Board ( IRB ) approve informed consent prior perform screen procedure opinion PI comply requirement study . Subject healthy , determine screen medical evaluation ( include limit medical history , physical examination clinical laboratory evaluation ) . Subject Caucasian . Female subject must nonchildbearing potential ( surgically sterile [ hysterectomy bilateral tubal ligation ] postmenopausal â‰¥ 1 year follicle stimulate hormone [ FSH ] &gt; 40 U/L ) . Women receive hormone replacement therapy ( HRT ) eligible enroll . Male subject must agree use condom refrain sperm donation Day 1 30 day post last dose documentation vasectomy . Subject body weight &gt; 50 kg body mass index ( BMI ) 19.5 32 kg/m2 , inclusive , screen . Subject clinically significant abnormal finding relate systolic diastolic blood pressure ( BP ) , per investigator 's judgment , screen Day 1 . Subject clinically significant abnormal finding 12 lead ECG , per investigator 's judgment , screen . Subject clinically significant history evidence cardiovascular , respiratory , hepatic , renal , gastrointestinal , endocrine , neurological , immunological , psychiatric disorder ( ) determine investigator designee . Subject clinically significant abnormality 12 lead ECG do screen Subject clinically significant abnormality 48hour ambulatory ECG do screen Subject disorder would interfere absorption , distribution , metabolism , excretion drug . Subject concurrent disease condition , opinion investigator , would make subject unsuitable participation clinical study . Subject unlikely comply protocol requirement , instruction , study related restriction ; e.g. , uncooperative attitude , unavailable followup call , and/or improbability complete clinical study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>N91115</keyword>
	<keyword>GSNORi</keyword>
	<keyword>SNO</keyword>
	<keyword>Cavosonstat</keyword>
</DOC>